VXRT: Positive safety data, BARDA funding, and cash runway into Q2 2027 amid lower revenueQuartr·Aug 6 at 06:45 PMVXRT-2.82%
Vaxart (OTCMKTS:VXRT) Posts Quarterly Earnings Results, Beats Expectations By $0.06 EPSMarket Beat·Aug 6 at 05:41 PMVXRT-2.82%IVZ+1.34%
Vaxart | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 27.19 MEarnings Watch·Aug 6 at 04:29 PMVXRT-2.82%
Vaxart names Kevin Finney, James Breitmeyer as board committee chairsPUBT·Jul 28 at 07:03 AMVXRT-2.82%
Vaxart management participates in BTIG Virtual Biotechnology Conference 1-on-1 meetingsPUBT·Jul 21 at 07:07 AMVXRT-2.82%
Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for NowMarket Beat·Jul 20 at 05:02 AMVXRT-2.82%
